Betadex sulfobutyl ether sodium(SBE-β-CD) provides the following improvement effects for formulations of poorly soluble drugs:
Increased solubility: SBE-β-CD can form inclusion complexes with poorly soluble drugs, enhancing the drug's solubility in water and facilitating better absorption and utilization.
Enhanced stability: Through the formation of inclusion complexes with SBE-β-CD, drug molecules become more stable in the environment, reducing susceptibility to factors such as light and oxygen and extending the drug's shelf life.
Improved oral absorption: SBE-β-CD can enhance the dissolution rate of drugs in the gastrointestinal tract, promoting drug absorption and increasing the drug's bioavailability.
Controlled drug release: SBE-β-CD can regulate the rate and manner of drug release, achieving sustained drug release in the body, thereby enhancing the drug's efficacy and safety.
Reduced dosage: By improving the drug's bioavailability, the use of SBE-β-CD can lower the drug dosage required for the same therapeutic effect, thereby reducing the adverse effects of the drug on the body.
Enhanced drug stability: SBE-β-CD can reduce drug crystallization and precipitation in formulations, improving drug stability and ensuring the quality and effectiveness of the formulation.
In conclusion, as a functional excipient, SBE-β-CD plays a vital role in formulations of poorly soluble drugs, enhancing drug solubility, stability, and bioavailability, improving formulation performance, and providing strong support for the efficacy and safety of drugs.
